Clonidine Extended-Release In Attention-Deficit Hyperactivity Disorder Profile Report

被引：1
|
作者：
Croxtall, Jamie D. [1 ]
机构：
[1] Adis, Auckland 0754, New Zealand
来源：
CNS DRUGS | 2012年 / 26卷 / 03期
关键词：
DEFICIT/HYPERACTIVITY DISORDER; CONTROLLED-TRIAL; DOUBLE-BLIND; CHILDREN; EFFICACY; ADHD;
D O I：
10.2165/11208310-000000000-00000
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：277 / 279
页数：3
相关论文
共 50 条
  • [21] Viloxazine extended-release capsules for the treatment of attention-deficit/ hyperactivity disorder in adult patients
    Childress, Ann
    Sottile, Robert
    Khanbijian, Sherine
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2023, 23 (11) : 945 - 953
  • [22] CLONIDINE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    ROSTAIN, AL
    POWER, TK
    MERCUGLIANO, M
    [J]. BIOLOGICAL PSYCHIATRY, 1993, 33 (6A) : A111 - A112
  • [23] Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder
    Martinez-Raga, Jose
    Knecht, Carlos
    de Alvaro, Raquel
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 1359 - 1370
  • [24] Guanfacine Extended Release in the Treatment of Attention-Deficit/Hyperactivity Disorder
    Rostain, Anthony L.
    [J]. CURRENT PSYCHIATRY REPORTS, 2009, 11 (05) : 339 - 340
  • [25] Dexmethylphenidate extended release in attention-deficit hyperactivity disorder - A viewpoint
    Masi, G
    Zuddas, A
    [J]. DRUGS, 2006, 66 (05) : 669 - 670
  • [26] Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder
    Wigal, Sharon B.
    Childress, Ann
    Berry, Sally A.
    Belden, Heidi
    Walters, Faith
    Chappell, Phillip
    Sherman, Nancy
    Orazem, John
    Palumbo, Donna
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2017, 27 (08) : 690 - 699
  • [27] Guanfacine extended release in the treatment of attention-deficit/hyperactivity disorder
    Anthony L. Rostain
    [J]. Current Psychiatry Reports, 2009, 11 : 339 - 340
  • [28] Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder
    Childress, Ann C.
    Wigal, Sharon B.
    Brams, Matthew N.
    Turnbow, John M.
    Pincus, Yulia
    Belden, Heidi W.
    Berry, Sally A.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (05) : 306 - 313
  • [29] EFFECTS OF EXTENDED-RELEASE METHYLPHENIDATE IN 109 CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: A CLINICAL ASSESSMENT
    Ishida, Y.
    Miyajima, T.
    Morichi, S.
    Suganami, Y.
    Oana, S.
    Yamanaka, G.
    Hoshika, A.
    [J]. PEDIATRIC RESEARCH, 2010, 68 : 462 - 462
  • [30] Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents
    Maletic, Vladimir
    Mattingly, Gregory W.
    Earnest, Jami
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2024, 24 (05) : 443 - 455
12345